Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Frontiers in Immunology|February 4, 2020
Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCCKelvin Anderson, Nathan Ryan, Greta Volpedo, et al.Parasites & Vectors|June 6, 2013
Multilocus microsatellite signature and identification of specific molecular markers for Leishmania aethiopicaNigatu Kebede, Steve Oghumu, Alemayehu Worku, et al.Frontiers in Cellular and Infection Microbiology|May 5, 2020
The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic ApplicationsNathan Ryan, Kelvin Anderson, Greta Volpedo, et al.International Journal of Surgical Pathology|February 17, 2022
Intraneural Nodular Fasciitis of the Femoral Nerve with A Unique CTNNB1::USP6 Gene Fusion: Apropos of a Case and Review of LiteratureBryce Parkinson, Ashley Patton, Alan Rogers, et al.Oncoimmunology|July 30, 2016
A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cellsGayathri Natarajan, Steve Oghumu, Cesar Terrazas, et al.Experimental Parasitology|December 3, 2014
Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania majorRashmi Tuladhar, Steve Oghumu, Ran Dong, et al.Genes, Chromosomes & Cancer|June 26, 2023
Comprehensive molecular profile of primary cutaneous epithelioid rhabdomyosarcoma: A tumor genomically and molecularly related to malignant melanomaSaba Shafi, Manan Shah, Dan Jones, et al.The American Journal of Tropical Medicine and Hygiene|October 9, 2014
Pediatric cutaneous leishmaniasis in an endemic region in IndiaSaurabh Agrawal, Kanika Khandelwal, Ram A Bumb, et al.Genes, Chromosomes & Cancer|October 11, 2025
Durable Response to Pazopanib (Tyrosine Kinase Inhibitor) in a Patient With EWSR1::CREM Gene Fusion Positive Intra-Abdominal Unclassified Epithelioid SarcomaSaba Shafi, Dan Jones, Xiaokang Pan, et al.International Journal of Cancer|November 12, 2019
STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinomaNathan Ryan, Kelvin Anderson, Greta Volpedo, et al.Pageof 9